Skip to main content
Premium Trial:

Request an Annual Quote

Genomica Completes $13.6M Private Financing


BOULDER, Colo.--Genomica, which describes itself as a pharmacogenomics software company, completed a $13.6 million private placement of series B convertible preferred stock this month. Punk Ziegel managed the placement. Investors included the Kaufman Fund, Anvers L.P., Falcon Technology Partners, Invesco Global Health Sciences Fund, Arch Venture Partners, and Boulder Ventures. Skip Klein, a healthcare analyst with Kaufman, said of Genomica's Discovery Manager software, "Users I've spoken to praise the product for its industrial- strength quality and ease of use. It appears that Genomica has the chance to be the Bloomberg or the Microsoft of genomics." Genomica was established in 1996 by Thomas Marr to commercialize tools he and his team developed at Cold Spring Harbor Laboratory in New York.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.